Press Releases

The Biotechnology Innovation Organization (BIO) today applauded Iowa’s Senate for approving a new five-year production tax credit for renewable chemicals and helping to drive innovation in this new sector. Renewable chemicals will be defined in Iowa…

The U.S. Senate was unable to advance a national solution to GMO food labeling.  It is essential for Senate leaders to continue working to reach a much-needed compromise over the coming days, as failure to move forward allows costly and…

The Biotechnology Innovation Organization (BIO) announces the lineup for Super Sessions at the 2016 BIO International Convention, taking place in San Francisco’s Moscone Convention Center from June 6-9. Considered the global event for…

BIO President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative...

BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and ASPE Issue Briefs...

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations & Environment, will address biofuel and biorefining technology developers. McGinn…

Washington, D.C. (March 2, 2016) – The Biotechnology Innovation Organization (BIO) has announced a new partnership with UniFirst Corporation (NYSE: UNF), an industry leader in the supply and servicing of uniforms, workwear, and facility…

Legislation enhances transparency, protects farmersBIO applauds bipartisan action today by the Senate Agriculture Committee to advance a biotech food labeling solution as an alternative to a costly and confusing patchwork of state laws.

Washington, D.C. (February 26, 2016) – The Biotechnology Innovation Organization (BIO) Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s White House announcement of actions to…

“BIO extends our congratulations to Dr. Califf on his confirmation as Commissioner of the FDA, a job that carries tremendous responsibility in protecting public health and advancing biotechnology innovation.